Abstract
In the Rutaceae family Citrus maxima is the biggest among all fruits, tradtionally used for several purposes due to its diverse ethnomedicinal, phytochemical, and pharmacological activities. Different portions of this plant have been used as sedatives and anti-inflammatory medications, as well as to treat coughs, fevers, asthma, diarrhea, ulcers, and diabetes. There is a scientific potential for the methanolic seed extract to contain bioactive compounds, similar to those found in other parts of the plant. The extract derived from the seeds has already demonstrated potential biological activity. Moreover, there weren't many in vivo and in vitro research works on these plants' seeds. Therefore, the current research work was undertaken to analyze anti-diarrheal and antipyretic potentials of the methanolic extract of Citrus maxima seeds (MCM). To evaluate MCM's effectiveness in treating diarrhea, castor oil-induced diarrhea model was utilized as an evaluating method. The antipyretic effect in mice was measured using brewer's yeast induced pyrexia model. The MCM at 200 and 400 mg/kg doses markedly reduced hyperpyrexia, induced by yeast. The effect remained persistent up to 4th hour after administration. In the castor oil induced diarrhea model, the methanolic seed extract showed high level of dose dependent inhibition of diarrhea for 4 h following castor oil administration. Further investigation is necessary to elucidate and clarify the specific causative agents responsible for the dose-dependent effects observed. The findings of the present study suggest that MCM seed extract may represent a promising alternative for the development of innovative anti-diarrheal and anti-pyretic compounds.